Genomic Determinants of Responses to Immunotherapy in Merkel Cell Carcinoma

Project: Research project

Description

We will utilize genome sequencing to identify the genetic causes of primary and acquired resistance of Merkel cell carcinomas to immunotherapy.
StatusActive
Effective start/end date7/1/196/30/21

Funding

  • National Comprehensive Cancer Network (Agmt 6/24/19)

Fingerprint

Merkel Cell Carcinoma
Immunotherapy
Genome